Philip has been active in the medical cannabis space since 2018, initially overseeing the development and build-out of large-scale cannabis production facilities in Europe and later taking responsibility for the commercial distribution of medical cannabis across multiple EU countries.
In 2021, Philip joined Cantourage as Chief Executive Officer. Under his leadership, the company has built a first-of-its-kind market access platform for cultivators from around the globe, expanded rapidly across Europe, and established itself as a key player in Europe’s medical cannabis industry. Cantourage went public on the Frankfurt Stock Exchange in 2022, underlining its ambition to scale responsibly while improving patient access to high-quality cannabinoid medicines.
Philip holds degrees in industrial engineering from the Karlsruhe Institute of Technology and in economics from the University of Sydney. He regularly speaks on European cannabis regulation, supply chain innovation, and strategies for navigating complex regulatory environments.
Attend Cannabis Europa London 2026
General Release
VIP Experience
BoC Awards
Working with Prohibition Partners for Cannabis Europa has been an absolute pleasure. Their dedication, exceptional professionalism, and collaborative spirit have made a meaningful difference, and we sincerely value their support.
We were truly honoured to sponsor the VIP Lounge and be part of an event that continues to set the standard for meaningful dialogue and progress in the medical cannabis industry. We left feeling excited and optimistic about the future.
